Substance Use Disorders Clinical Trial
Official title:
A Prospective Cohort Study of Contingency Management Using A Smartphone Application in Patients With Substance Use Disorder
The purpose of this research study is to test the acceptance and efficacy of a smartphone app (DynamiCare Rewards) for patients with substance use disorder (SUD) who are in active treatment and recovery at BrightView.
The purpose of this research study was to test the acceptance and efficacy of a smartphone
app (DynamiCare Rewards) for patients with substance use disorder (SUD) who are in active
treatment and recovery at BrightView (www.brightviewhealth.com). Patients performed
self-tracking of their recovery behavior (e.g., counseling attendance, abstinence from drugs
and alcohol) addiction recovery behavior using the DynamiCare app, which follows Contingency
Management (CM) model of incentivizing positive behavior.
CM is shown as a highly effective, evidence-based methodology for improving substance use
disorder (SUD) outcomes. It does so by activating the brain's reward and inhibitory systems
through both positive and negative reinforcement using immediate, concrete incentives in a
progressive reinforcement schedule. CM involves setting frequent (>1/week), objective goals
(usually abstinence or participation in treatment), which patients can achieve to earn
tangible rewards (such as cash or vouchers). The DynamiCare smart phone app (iOS/Android)
uses CM to incentivize patients to attend scheduled appointments and to submit negative
alcohol and drug tests as they are rewarded for these behaviors. The intentions of this
project were to assess whether use of the smartphone app as an add-on to treatment as usual
could increase treatment retention, increase the percentage of appointments that were kept,
and if substance use could be reduced for patients using the app.
Patients were enrolled in the study on a rolling basis from Jan 25, 2019 to March 29, 2019
until the desired cohort group # was reached (n=108). The intervention period (period of time
when patients actually used the DynamiCare app) lasted four months from the date of their
enrollment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05660434 -
Using Aromatherapy in Substance Use Disorder
|
N/A | |
Active, not recruiting |
NCT05338268 -
Substance Use and Loneliness
|
N/A | |
Completed |
NCT03954184 -
E-health Implementation (Iowa)
|
N/A | |
Completed |
NCT04098614 -
Barriers to Substance Use Disorder Recovery
|
N/A | |
Completed |
NCT03590106 -
Cardiac Surgery Peer Recovery Support Program
|
N/A | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Recruiting |
NCT06273228 -
Parenting Young Children in Pediatrics
|
N/A | |
Recruiting |
NCT05327504 -
Written Exposure Therapy for Veterans With SUD and PTSD
|
N/A | |
Terminated |
NCT03517111 -
The Impact of a Parenting Intervention on Latino Youth Health Behaviors
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT04401215 -
Technologically-Augmented Referrals to Mitigate Addiction Consequences
|
N/A | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Not yet recruiting |
NCT06187701 -
Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Active, not recruiting |
NCT02382042 -
Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans
|
N/A | |
Terminated |
NCT01356667 -
Drum-Assisted Therapy for Native Americans
|
N/A | |
Completed |
NCT01237366 -
Study Targeting Affect Regulation
|
Phase 1/Phase 2 | |
Completed |
NCT00708890 -
Twelve Step Based Self-help Groups for Substance Related Disorders
|
N/A | |
Active, not recruiting |
NCT04048850 -
Zepatier in Patients With Substance Use
|
||
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 |